Alcidion announces that an agreement has been reached with Dartford and Gravesham NHS Trust, UK, to implement the OPENeP Electronic Prescribing and Medications Administration (ePMA) system produced by Better. Total value of the contract is £1.02 million (~A$1.9 million) to be recognised over six years.
The agreement follows Alcidion’s award as preferred provider by the Trust, a status previously announced in July 2019 and subject to final approval by the Trust and successful negotiation of terms.
Alcidion was appointed as a reseller and implementer of the OPENeP solution in April 2019 for the UK, Australia and New Zealand health sectors. This project will represent Alcidion’s first implementation of OPENeP.
The agreement extends Alcidion’s existing relationship with Dartford and Gravesham, where a contract was signed earlier in 2019 for the first implementation of Alcidion’s full product suite in the UK. The Patientrack solution was implemented earlier this year, and planning is currently underway to implement the Miya Precision and Smartpage solutions.
Dartford and Gravesham is a forward-looking NHS Trust with an ambitious strategic plan of achieving full digital maturity by the adoption of integrated, best of breed technology solutions and being Paperless at the Point of Care by 2020.
Neil Perry, Director, Digital Transformation said “We were excited by the range of technologies that Alcidion could provide us to achieve our objectives. Alcidion’s partnership with Better allows us to address electronic prescribing and medications management to further complete the picture”.
The comprehensive medication management information arising from OPENeP will be fully integrated with the powerful capabilities of Miya Precision, enhancing clinical decision support and extending the scope of the electronic patient record.
Roko Malkoč, Business Unit Manager, OPENeP, commented “Patients should be the focus, and it is in their interest to always get accurate treatment of the highest quality. By collaborating with Alcidion at Dartford and Gravesham NHS Trust, we aim to create an environment which maximises patient safety, improves collaboration among staff, and prevents unnecessary errors. All this will lead to better patient outcomes”.
Alcidion Managing Director Kate Quirke commented “After receiving preferred provider status in July, we are delighted to extend our existing relationship with the Dartford and Gravesham NHS Trust. Our approach to improving healthcare delivery is closely aligned with the goals of the Trust and we are excited to demonstrate the effectiveness of the consolidated solution.”